{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:07:47Z","timestamp":1788916067156,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.preghy.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T18:06:15Z","timestamp":1521482775000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Increased serum levels of sFlt-1\/PlGF ratio in preeclamptic women with onset at &lt;32\u202fweeks compared with \u226532\u202fweeks"],"prefix":"10.1016","volume":"12","author":[{"given":"Hirotada","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-0606","authenticated-orcid":false,"given":"Kayo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-1572","authenticated-orcid":false,"given":"Akihide","family":"Ohkuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2018.03.008_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0146-0005(99)80059-7","article-title":"Prediction of preeclampsia","volume":"23","author":"Myatt","year":"1999","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.preghy.2018.03.008_b0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1447-0756.2012.01990.x","article-title":"Comparison of risk factors for gestational hypertension and preeclampsia in Japanese singleton pregnancies","volume":"39","author":"Shiozaki","year":"2013","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.preghy.2018.03.008_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14390\/jsshp.1.3","article-title":"Outline of definition and classification of \u201cPregnancy induced Hypertension (PIH)\u201d","volume":"1","author":"Watanabe","year":"2013","journal-title":"Hypertens. Res. Pregnancy"},{"key":"10.1016\/j.preghy.2018.03.008_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","article-title":"The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"3","author":"Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2018.03.008_b0025","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1001\/jama.283.20.2661","article-title":"Causes of maternal mortality in Japan","volume":"283","author":"Nagaya","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.preghy.2018.03.008_b0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1447-0756.1999.tb01187.x","article-title":"Causes of stillbirth: an analysis of 77 cases","volume":"25","author":"Yamauchi","year":"1999","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.preghy.2018.03.008_b0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"von Dadelszen","year":"2003","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2018.03.008_b0040","first-page":"1026","article-title":"Prediction of early-onset preeclampsia using uterine artery Doppler","volume":"2","author":"Ohkuchi","year":"2014","journal-title":"Med. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.03.008_b0045","first-page":"1025","article-title":"Prediction of early-onset preeclampsia using angiogenesis-related factors","volume":"2","author":"Hirashima","year":"2014","journal-title":"Med. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.03.008_b0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2018.03.008_b0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1291\/hypres.30.151","article-title":"Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia","volume":"30","author":"Ohkuchi","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.preghy.2018.03.008_b0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/HYPERTENSIONAHA.111.174417","article-title":"Threshold of soluble fms-like tyrosine kinase 1\/placental growth factor ratio for the imminent onset of preeclampsia","volume":"58","author":"Ohkuchi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2018.03.008_b0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/hr.2013.95","article-title":"Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19\u201331 weeks of gestation","volume":"36","author":"Ohkuchi","year":"2013","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.preghy.2018.03.008_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/hr.2016.107","article-title":"Prediction and prevention of hypertensive disorders of pregnancy","volume":"40","author":"Ohkuchi","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.preghy.2018.03.008_b0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/hr.2010.15","article-title":"Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia","volume":"33","author":"Ohkuchi","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.preghy.2018.03.008_b0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/00016340701819262","article-title":"Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia","volume":"87","author":"Wikstr\u00f6m","year":"2008","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2018.03.008_b0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pd.2203","article-title":"The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia","volume":"29","author":"Kim","year":"2009","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2018.03.008_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.2009.02453.x","article-title":"Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia","volume":"117","author":"Masuyama","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2018.03.008_b0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/08977191003662651","article-title":"Levels of antiangiogenic factors in preeclamptic pregnancies","volume":"28","author":"Zhao","year":"2010","journal-title":"Growth Factors"},{"key":"10.1016\/j.preghy.2018.03.008_b0100","doi-asserted-by":"crossref","first-page":"469.e1-8","DOI":"10.1016\/j.ajog.2011.06.058","article-title":"Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays","volume":"205","author":"Benton","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.03.008_b0105","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3109\/09513590.2011.650759","article-title":"Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia","volume":"28","author":"Sezer","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.preghy.2018.03.008_b0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5830\/CVJA-2012-003","article-title":"The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia","volume":"23","author":"Govender","year":"2012","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.preghy.2018.03.008_b0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0897.2012.01158.x","article-title":"Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia","volume":"68","author":"Boij","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2018.03.008_b0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.preghy.2013.02.002","article-title":"Measurement of sST2 is comparable to PlGF in the diagnosis of early-onset pre-eclampsia","volume":"3","author":"Southcombe","year":"2013","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2018.03.008_b0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpm-2012-0248","article-title":"The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome","volume":"41","author":"Schaarschmidt","year":"2013","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.preghy.2018.03.008_b0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aogs.12366","article-title":"Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia","volume":"93","author":"Tobinaga","year":"2014","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2018.03.008_b0135","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/pd.4432","article-title":"The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia","volume":"34","author":"Pinheiro","year":"2014","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2018.03.008_b0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jash.2014.11.008","article-title":"Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1\/placental growth factor ratio: an inter-assay comparison","volume":"9","author":"Andersen","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.preghy.2018.03.008_b0145","doi-asserted-by":"crossref","first-page":"e0126815","DOI":"10.1371\/journal.pone.0126815","article-title":"Circulating angiogenic factors and the risk of adverse outcomes among haitian women with preeclampsia","volume":"10","author":"March","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.preghy.2018.03.008_b0150","doi-asserted-by":"crossref","first-page":"89.e1","DOI":"10.1016\/j.ajog.2016.01.168","article-title":"Sequential plasma angiogenic factors levels in women with suspected preeclampsia","volume":"215","author":"Baltajian","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.03.008_b0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0032-1328601","article-title":"Prenatal clinical assessment of sFlt-1 (soluble fms-like tyrosine kinase-1)\/PlGF (placental growth factor) ratio as a diagnostic tool for preeclampsia, pregnancy-induced hypertension, and proteinuria","volume":"73","author":"Lehnen","year":"2013","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.preghy.2018.03.008_b0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1515\/cclm-2013-0901","article-title":"New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis","volume":"52","author":"\u00c1lvarez-Fern\u00e1ndez","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.preghy.2018.03.008_b0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preghy.2014.02.002","article-title":"How accurate are placental growth factor, urate, lactate dehydrogenase and proteinuria in diagnosing preeclampsia and its severity?","volume":"4","author":"Khalil","year":"2014","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2018.03.008_b0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2018.03.008_b0175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.clinbiochem.2015.06.020","article-title":"Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia","volume":"48","author":"van Helden","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.preghy.2018.03.008_b0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/10641955.2016.1141214","article-title":"A comparison of the diagnostic utility of the sFlt-1\/PlGF ratio versus PlGF alone for the detection of preeclampsia\/HELLP syndrome","volume":"35","author":"Stepan","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2018.03.008_b0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.medici.2016.11.008","article-title":"sFlt-1, PlGF, sFlt-1\/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics","volume":"52","author":"Tarasevi\u010dien\u0117","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.preghy.2018.03.008_b0190","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstet. Gynecol."}],"updated-by":[{"DOI":"10.1016\/j.preghy.2019.01.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000}}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:43:42Z","timestamp":1658144622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917304208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"alternative-id":["S2210778917304208"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.03.008","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.preghy.2019.01.006","asserted-by":"object"}]},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum levels of sFlt-1\/PlGF ratio in preeclamptic women with onset at <32\u202fweeks compared with \u226532\u202fweeks","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}